China Medical System Holdings Limited
CHSYFOTCHealthcare● Active
$0.93
$-0.42(-31.06%)
Market Cap$2.3B
P/E Ratio—
52W High$1.6358
52W Low$0.9307
China Medical System Holdings Limited (CHSYF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CHSYF · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 16, 2026EPS Actual
$0.03
Est. $0.04 · -20.7%
Revenue
$0.60B
Est. $0.60B · -0.5%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 16, 2026
After Market Close
▼ Miss EPS
CHSYF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | $0.06 | — | — | — | $0.70B | — |
| ▼ Q1 FY2026 | Mar 16, 2026 | $0.04 | $0.03 | -20.7% | $0.60B | $0.60B | -0.5% |
| ▲ Q3 FY2025 | Aug 18, 2025 | $0.05 | $0.05 | +5.1% | $0.56B | $0.56B | -0.1% |
| ▼ Q1 FY2025 | Mar 17, 2025 | $0.05 | $0.04 | -14.1% | $0.53B | $0.56B | -5.1% |
| ▲ Q3 FY2024 | Aug 15, 2024 | $0.04 | $0.05 | +16.7% | $0.50B | $0.50B | -1.6% |
| ▼ Q2 FY2024 | May 9, 2024 | $0.08 | $0.03 | -63.7% | $0.48B | $0.60B | -19.3% |
| ▲ Q2 FY2023 | Jun 30, 2023 | $0.10 | $0.11 | +8.9% | $0.64B | $0.68B | -6.3% |
| ▼ Q4 FY2022 | Dec 31, 2022 | $0.09 | $0.09 | -4.7% | $0.69B | $0.69B | -0.6% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
$0.06
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 16, 2026Miss
EPS Actual
$0.03
EPS Est.
$0.04
EPS Surpr.
-20.7%
Revenue
$0.60B
Q3 FY2025
Aug 18, 2025Beat
EPS Actual
$0.05
EPS Est.
$0.05
EPS Surpr.
+5.1%
Revenue
$0.56B
Q1 FY2025
Mar 17, 2025Miss
EPS Actual
$0.04
EPS Est.
$0.05
EPS Surpr.
-14.1%
Revenue
$0.53B
Q3 FY2024
Aug 15, 2024Beat
EPS Actual
$0.05
EPS Est.
$0.04
EPS Surpr.
+16.7%
Revenue
$0.50B
Q2 FY2024
May 9, 2024Miss
EPS Actual
$0.03
EPS Est.
$0.08
EPS Surpr.
-63.7%
Revenue
$0.48B
Q2 FY2023
Jun 30, 2023Beat
EPS Actual
$0.11
EPS Est.
$0.10
EPS Surpr.
+8.9%
Revenue
$0.64B
Q4 FY2022
Dec 31, 2022Miss
EPS Actual
$0.09
EPS Est.
$0.09
EPS Surpr.
-4.7%
Revenue
$0.69B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.30 | $0.30 | $0.30 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.37 | $0.37 | $0.37 | 1 |
| Q2 FY2024 | $0.35 | $0.35 | $0.35 | 1 |
| Q4 FY2023 | $0.53 | $0.53 | $0.53 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $30.2B | $30.2B | $30.2B | 1 |
| Q3 FY2025 | $4.0B | $4.0B | $4.0B | 1 |
| Q2 FY2025 | $28.7B | $28.7B | $28.7B | 1 |
| Q2 FY2024 | $27.7B | $27.7B | $27.7B | 1 |
| Q4 FY2023 | $29.9B | $29.9B | $29.9B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Mar 16, 2026 | -20.7% | $1.35 | $1.35 | +0.00% |
| ▲ Q3 FY2025 | Aug 18, 2025 | +5.1% | $1.35 | $1.35 | +0.00% |
| ▼ Q1 FY2025 | Mar 17, 2025 | -14.1% | $0.93 | $0.93 | +0.00% |
| ▲ Q3 FY2024 | Aug 15, 2024 | +16.7% | $0.93 | $0.93 | +0.00% |
| ▼ Q2 FY2024 | May 9, 2024 | -63.7% | $0.93 | $0.93 | +0.00% |
| ▲ Q2 FY2023 | Jun 30, 2023 | +8.9% | $1.46 | $1.46 | +0.00% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -4.7% | $1.38 | $1.38 | +0.00% |
| ▲ Q2 FY2022 | Jun 30, 2022 | -1.0% | $1.59 | $1.59 | +0.00% |
Q1 FY2026+0.00%
Report Date
Mar 16, 2026
EPS Beat/Miss
-20.7%
Price Before
$1.35
Price After
$1.35
Q3 FY2025+0.00%
Report Date
Aug 18, 2025
EPS Beat/Miss
+5.1%
Price Before
$1.35
Price After
$1.35
Q1 FY2025+0.00%
Report Date
Mar 17, 2025
EPS Beat/Miss
-14.1%
Price Before
$0.93
Price After
$0.93
Q3 FY2024+0.00%
Report Date
Aug 15, 2024
EPS Beat/Miss
+16.7%
Price Before
$0.93
Price After
$0.93
Q2 FY2024+0.00%
Report Date
May 9, 2024
EPS Beat/Miss
-63.7%
Price Before
$0.93
Price After
$0.93
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
+8.9%
Price Before
$1.46
Price After
$1.46
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
-4.7%
Price Before
$1.38
Price After
$1.38
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
-1.0%
Price Before
$1.59
Price After
$1.59
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate4 / 8 quarters
Largest Move+0.00% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CHSYF ends December
China Medical System Holdings Limited (CHSYF) most recently reported earnings on March 16, 2026 for Q1 FY2026, posting EPS of $0.03 — missing the analyst consensus of $0.04 by -20.7%. The next CHSYF earnings date is expected around September 1, 2026.
Each quarter, investors track CHSYF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CHSYF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CHSYF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CHSYF earnings · 5 questionsChina Medical System Holdings Limited's next earnings report is expected around September 1, 2026. CHSYF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CHSYF historically reports after market close (AMC).
CHSYF earnings datewhen is CHSYF earningsCHSYF next earnings datewhen does CHSYF report earningsCHSYF earnings calendar
▸ Source: FMP · China Medical System Holdings Limited SEC filings · US GAAP · China Medical System Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026